Guardant Health, Inc.
Company Information
Industry
Services-Medical Laboratories
SIC Code
8071
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
DE
Business Address
3100 HANOVER STREET, PALO ALTO, CA, 94304
Mailing Address
3100 HANOVER STREET, PALO ALTO, CA, 94304
Phone
855-698-8887
Fiscal Year End
1231
EIN
454139254
Financial Overview
FY2025
$2.11B
Total Liabilities
$158.68M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
Annual Reports
10-K
February 19, 2026
- Reported growth in total revenue, driven by increased adoption of clinical testing services and expanded biopharmaceutical partnerships.
- Settlement of the patent infringement lawsuit removed significant legal uncertainty and potential financial liability.
Insider Trading
STRONG SELL
10 insiders
53 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.